|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Net revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Operating expenses: | ||
| Selling and marketing expenses | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Total operating expenses | ||
| Other (expenses)/income, net: | ||
| Financial expenses, net | ||
| Loss on fair value change | ||
| Other income | ||
| Total other expenses, net | ||
| Loss before income tax expense | ||
| Income tax benefits/(expenses) | ||
| Net loss | ||
| Other comprehensive income/(loss): | ||
| Foreign currency translation adjustments | ||
| Total comprehensive loss | ||
| Weighted average number of Ordinary Shares – basic (in Shares) | ||
| Weighted average number of Ordinary Shares – diluted (in Shares) | ||
| Basic loss per ordinary share (in Dollars per share) | ||
| Diluted loss per ordinary share (in Dollars per share) |
Loading...
